Radioimmunoassay Market: Key Players
This Radioimmunoassay market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Radioimmunoassay market.
Quantification of a specific protein in a complex sample is a valuable contribution in the field of medical science. Immunoassays use the highly specific antibodies to target specific molecule of interest and analyze its concentration in a sample. Thus, immunoassay can be defined as a biochemical procedure which is used to measure the concentration of specific antigen with a specific antibody. The first immunoassay was developed in 1959 wherein radiolabeled insulin was used to determine the concentration of insulin in human plasma. Radioimmunoassay (RIA) is a medical diagnostic procedure used to measure the concentration of specific antigens by using specific antibodies. RIA is a highly sensitive technique using which any biological substance for which a specific antibody exists can be quantified, in a very minute concentrations. Radioimmunoassay is the first immunoassay technique using which Nano molar and Pico molar concentrations of hormones in biological fluids can be determined. RIA technique relies on a very basic principle of competitive binding where a radioactive antigen competes with non-radioactive antigen for a specific antibody. RIA technique finds application in various areas of disease diagnosis such as it is used in early detection and diagnosis of cancer, it is also used in diagnosis of various other infectious diseases including neurodegenerative disorders. RIA is considered as one of the most pivotal and traditional method used for endocrine disorders diagnosis. In pharmaceutical industry RIA is used for drug testing. The market for RIA is expected to witness a significant growth rate over the forecast period owing to rising use of radioimmunoassay techniques in cancer diagnosis and advancements in medical research.
The global radioimmunoassay market is expected to exhibit a single digit CAGR over the forecast period (2016-2026).
Market Growth Analysis
Global Industry Analysis and Opportunity Assessment 2016-2026
The global radioimmunoassay market is expected to experience a considerable growth over the forecast period driven by rising prevalence of cancer and various other infectious diseases. The increasing use of RIA procedures in research centers, contract research organizations and pharmaceutical industries is also driving the overall growth of radioimmunoassay market over the forecast period. Furthermore rising demand for high throughput and automated procedures in research centers and diagnostic labs to ensure patients satisfaction in getting error free results are some of the key factors driving the radioimmunoassay market growth over the forecast period.
Factors responsible for restraining the growth of global radioimmunoassay market include, high cost of the procedure and continuous innovations in various other immunoassay procedures such as ELISA.
Radioimmunoassay Market: Segmentation
Radioimmunoassay Market: Overview
With rising incidence of cancer, endocrine disorders along with various other infectious diseases and increased use of radioimmunoassay procedure in pharmaceutical industry for drug testing, the global radioimmunoassay market is expected to have a robust growth over the forecast period (2016-2026). Other factors driving the growth of radioimmunoassay market include rapid advancements in medical research and increased spending in research and development and life science sector. The use of radioimmunoassay in diagnosing neurodegenerative disorders is also fueling the market growth.
Radioimmunoassay Market: Region- wise Outlook
The global market for radioimmunoassay is expected to register a healthy CAGR during the forecast period. Depending on geographic regions, global Biopsy Device market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa.
Some of the key market players in global radioimmunoassay market are DIAsource ImmunoAssays, Beckman Coulter, Inc., IBL Internationa, PerkinElmer, Inc, DRG International, Inc., MP Biomedicals, LLC, Cisbi, Euro Diagnostica AB, DiaSorin S.p.A., EMD Millipore, Izotop, Berthold Technologies GmbH.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.
Competitive Positioning Matrix
Average Selling Price (ASP) Analysis
Global Radioimmunoassay Marketis segmented on the basis of product, application, end use and geography as following:
- By Product
- Kits and Reagents
- By Application
- Scientific Research
- Medical Diagnosis
- By End User
- Pharmaceutical and Biotechnology Industry
- Academic Research Institute
- Contract Research Organizations
In terms of region Europe accounts for the largest market shares in global radioimmunoassay market owing to advancements in medical research, clinical trials, growing geriatric population with cancer indication. Also prevalence of various other infectious diseases in the region is expected to drive the radioimmunoassay market growth in the near future. North America holds the second largest share in the global radioimmunoassay market. The market for radioimmunoassay in North America is particularly driven by gradually increasing awareness, rising incidence of cancer patients and adoption of advanced technologies in research sectors. Increased investment by government and nongovernment organizations in establishment of research centers is also expected to drive the growth of radioimmunoassay market in North America. Asia pacific is expected to represent lucrative market growth in the radioimmunoassay market owing to rapidly aging population and rise in application of radioimmunoassay technique in cancer diagnosis.
Radioimmunoassay Market: Key Players
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, ASEAN, Australia & New Zealand)
- Middle East and Africa (GCC, S. Africa, N. Africa)
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.